SCHEMBL15070204

SCHEMBL15070204

CC(=O)c1c(C(C)=O)c(-c2ccnc(F)c2)n(C)c1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.39
CDC7 O00311 1/20 0.39
CTSA P10619 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
GRM5 P41594 2/20 0.37
ALDH1A1 P00352 2/20 0.36
CSF1R P07333 1/20 0.36
FGFR1 P11362 1/20 0.36
FLT1 P17948 1/20 0.36
KDR P35968 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CDK8 P49336 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
PRKCQ Q04759 1/20 0.36
LRRK2 Q5S007 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15070377 0.92 GABRA1 (0.41) PDE10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL9065801 0.86 GABRA1 (0.44) PDE10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL15070369 0.74 CYP11B2 (0.48) ALDH1A1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL15070199 0.73 MEN1 (0.46) ALDH1A1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL15074638 0.70 NSD3 (0.49) PDE10ACDC7ALDH1A1CSNK1A1GSK3B
SCHEMBL21333215 0.70 NOTUM (0.48) CTSAGRM5ALDH1A1MAPT
SCHEMBL31472663 0.70 NOTUM (0.48) CTSAGRM5ALDH1A1MAPT
SCHEMBL4581815 0.70 KDM4C (0.55) PDE10ACTSAKDM4CGRM5ALDH1A1
SCHEMBL8212224 0.69 NSD3 (0.41) PDE10AGRM5ALDH1A1SMN1; SMN2MAPK14
SCHEMBL15070203 0.68 GABRA1 (0.47) ALDH1A1MAPTRAB9AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165483-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165483-A1 HETEROARYLS AND USES THEREOF PIK3R5, PIK3R4, PIK3C2B PDE10A 3390/4885CDC7 793/4885CTSA 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.